[-] Show simple item record

Angiotensin blockade for diabetes: Monitor microalbuminuria?

URI
http://hdl.handle.net/10355/3594
dc.contributor.authorMuench, Johneng
dc.contributor.authorBlenning, Carol E.eng
dc.contributor.authorJudkins, Dolores Zegareng
dc.date.issued2007eng
dc.description.abstractNo studies address whether continued screening for microalbuminuria once a patient is taking an angiotensin-converting enzyme (ACE) inhibitor or angiotensin-2 receptor blocker (ARB) improves outcomes. Indirect evidence and expert opinion suggest that it may be beneficial to continue microalbuminuria surveillance to assess response to therapy and monitor disease progression (strength of recommendation: C, based on expert opinion).eng
dc.identifier.urihttp://hdl.handle.net/10355/3594eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionClinical Inquiries, 2007 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.relation.ispartofseriesJournal of family practice, 56, no. 02 (February 2007): 145-146eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectangiotensin-converting enzyme (ACE) inhibitoreng
dc.subjectdisease progressioneng
dc.subjectpatient monitoringeng
dc.subjectdiabetes mellituseng
dc.subject.lcshAlbuminuriaeng
dc.subject.lcshDiabetes -- Complicationseng
dc.subject.lcshDiabetic nephropathieseng
dc.titleAngiotensin blockade for diabetes: Monitor microalbuminuria?eng
dc.typeArticleeng


Files in this item

[PDF]
Name:
AngiotensinBlockadeDiabetes.pdf
Size:
88.07Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

[-] Show simple item record